1972
DOI: 10.1038/238288a0
|View full text |Cite
|
Sign up to set email alerts
|

Dextrans and Fibrin Morphology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

1974
1974
2008
2008

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(12 citation statements)
references
References 3 publications
0
12
0
Order By: Relevance
“…LMWD, which has a molecular weight of 40,000 Daltons, has been found to be an effective anticoagulation agent 8 . Even though its mechanism in anticoagulation remains unclear, it is thought that dextran exerts its effects on fibrin 9 . It is also conceivable that the ability of dextran to cause intravascular volume expansion can be one mechanism for its anticoagulation activity.…”
Section: Discussionmentioning
confidence: 99%
“…LMWD, which has a molecular weight of 40,000 Daltons, has been found to be an effective anticoagulation agent 8 . Even though its mechanism in anticoagulation remains unclear, it is thought that dextran exerts its effects on fibrin 9 . It is also conceivable that the ability of dextran to cause intravascular volume expansion can be one mechanism for its anticoagulation activity.…”
Section: Discussionmentioning
confidence: 99%
“…Most experiments and clinical observations indicate that when early occlusion occurs, it does so at the site of the anastomosis and is dependent on fibrin formation. 3 Muzzafar et al 4 demonstrated that dextrans interfere with the formation of this fibrin network, thus preventing the aggregation of red thrombi. This finding has been supported by other studies, which found that dextrans achieve their antithrombotic effect mainly by affecting fibrin rather than platelet aggregation.…”
Section: Mode Of Actionmentioning
confidence: 98%
“…Dextran is cleared renally, with the renal clearance inversely proportional to the size of the molecule; therefore, the half-life of dextran relates to its molecular weight, ranging from 7.5 to 12 hours. 16 Dextran has multiple effects, including platelet inhibition, 17 diminished fibrin polymerization, 18 decreased blood viscosity and erythrocyte rouleaux formation, 19 and an increase in plasma volume. Physicians need to treat patients with congestive heart failure with caution, and patients with borderline renal function may experience deterioration in their kidney function.…”
Section: Dextran-like Compoundsmentioning
confidence: 99%